Market revenue in 2023 | USD 281.4 million |
Market revenue in 2030 | USD 396.0 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.52% in 2023. Horizon Databook has segmented the UK crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Paracetamol is used to treat pain in massive quantities, measured not in tablets but in thousands of tons. According to a University of Oxford research published in October 2022, the amount of paracetamol sold in the UK is estimated to be under 6,300 tons per year, which is 35 tons per million people:
35 grams or 70 paracetamol tablets per person per year. Paracetamol is available in solitary tablet form, cold & flu, and headache medicines. Every year, approximately 200 million packs of paracetamol are sold without a prescription in the UK; however, sales have decreased since pack size restrictions were implemented.
Overdosing, on the other hand, is a major drawback of medication. The majority of people are unaware of the maximum daily dose of paracetamol; an estimated one in every four people in the UK frequently exceeds the maximum daily dose.
Horizon Databook provides a detailed overview of country-level data and insights on the UK crocin market , including forecasts for subscribers. This country databook contains high-level insights into UK crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account